Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations.
To achieve malarial elimination, we must employ interventions that reduce the exposure of human populations to infectious mosquitoes. To this end, numerous antimalarial drugs are under assessment in a variety of transmission-blocking assays which fail to measure the single crucial criteria of a succ...
Hoofdauteurs: | Upton, L, Brock, P, Churcher, T, Ghani, A, Gething, P, Delves, M, Sala, K, Leroy, D, Sinden, R, Blagborough, A |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
2015
|
Gelijkaardige items
-
Transmission-blocking interventions eliminate malaria from laboratory populations
door: Blagborough, A, et al.
Gepubliceerd in: (2013) -
The design and interpretation of laboratory assays measuring mosquito transmission of Plasmodium.
door: Sinden, R, et al.
Gepubliceerd in: (2012) -
The design and interpretation of laboratory assays measuring mosquito transmission of Plasmodium
door: Sinden, R, et al.
Gepubliceerd in: (2012) -
A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines
door: Delves, M, et al.
Gepubliceerd in: (2012) -
A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines.
door: Delves, M, et al.
Gepubliceerd in: (2012)